Specialty pharmaceutical company

Providing solutions to unmet medical needs.

Shield Therapeutics is a specialty pharmaceutical company focused on the development and commercialisation of late‑stage, hospital‑focused pharmaceuticals which address areas of unmet medical need.

Find out more

Shield Therapeutics CEO hails positive head-to-head Feraccru study results

Mar 2019 - 5:28
View all Investors Audio & Video

Our Products

A treatment for iron deficiency anaemia

Our lead product, Feraccru®, is a novel oral ferric iron therapy that is approved and marketed in the European Union for the treatment of Iron Deficiency (ID) with or without anaemia in adults and in Switzerland for the treatment of Iron Deficiency Anaemia (IDA) in adults with inflammatory bowel disease (IBD).

Find out more

PM Society Awards Gold winner for Events & Exhibitions

Awarded Company of the Year at the 2016 Bionow Awards

London, UK

16 Upper Woburn Place
Euston
London, WC1H 0AF

t+44 (0) 207 186 8500

einfo@shieldtx.com

Newcastle, UK

Northern Design Centre
Baltic Business Quarter
Gateshead Quays, NE8 3DF

t+44 (0) 191 511 8500

einfo@shieldtx.com

Wollerau, Switzerland

Sihleggstrasse 23,
8832 Wollerau
Switzerland

t+41 (0) 435 080 781

einfo@shieldtx.com

Munich, Germany

Oranienburger Str. 3
c/o Lambsdorff Rechtsanwälte PartGmbB
10178 Berlin
Germany

t+44 (0) 207 186 8500

einfo@shieldtx.com